FDA Orange Book · active-ingredient family
Prednisolone sodium phosphate
Prednisolone sodium phosphate is approved as 4 brand and 35 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ORAPRED ODT · NDA 021959
4
Brand (NDA)
35
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, ointment, solution, solution/drops, tablet, orally disintegrating
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ORAPRED ODTRLD×3 | ADVANZ PHARMA | NDA 021959 | — | Jun 01, 2006 | |
| PEDIAPREDRLD | PAI HOLDINGS | NDA 019157 | AA | May 28, 1986 | |
| HYDELTRASOL | MERCK | NDA 011583 | — | Approved Prior to Jan 1, 1982 | |
| HYDELTRASOL | MERCK | NDA 011028 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (35)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PREDNISOLONE SODIUM PHOSPHATE | AMNEAL | ANDA 216715 | AA | Oct 25, 2022 | |
| PREDNISOLONE SODIUM PHOSPHATE | PHARM ASSOC | ANDA 204962 | — | Mar 11, 2020 | |
| PREDNISOLONE SODIUM PHOSPHATE×4 | EDENBRIDGE PHARMS | ANDA 203559 | AA | Dec 20, 2016 | |
| PREDNISOLONE SODIUM PHOSPHATE×3 | RISING | ANDA 202179 | — | Apr 10, 2013 | |
| PREDNISOLONE SODIUM PHOSPHATE | MISSION PHARMA | ANDA 091396 | AA | Sep 13, 2010 | |
| PREDNISOLONE SODIUM PHOSPHATE | PH HEALTH | ANDA 079010 | — | May 26, 2009 | |
| PREDNISOLONE SODIUM PHOSPHATE | AMNEAL PHARMS | ANDA 078345 | — | Mar 10, 2009 | |
| PREDNISOLONE SODIUM PHOSPHATE | PHARM ASSOC | ANDA 078988 | AA | Jun 09, 2008 | |
| PREDNISOLONE SODIUM PHOSPHATE | PHARM ASSOC | ANDA 078465 | AA | Mar 07, 2008 | |
| PREDNISOLONE SODIUM PHOSPHATE | VINTAGE PHARMS | ANDA 078416 | — | Oct 31, 2007 | |
| PREDNISOLONE SODIUM PHOSPHATE | NESHER PHARMS | ANDA 076982 | — | May 24, 2005 | |
| PREDNISOLONE SODIUM PHOSPHATE | NESHER PHARMS | ANDA 076988 | — | May 24, 2005 | |
| PREDNISOLONE SODIUM PHOSPHATE | PHARM ASSOC | ANDA 076913 | AA | Apr 25, 2005 | |
| PREDNISOLONE SODIUM PHOSPHATE | PHARMOBEDIENT | ANDA 076895 | — | Oct 04, 2004 | |
| PREDNISOLONE SODIUM PHOSPHATE | CHARTWELL RX | ANDA 075988 | AA | May 25, 2004 | |
| PREDNISOLONE SODIUM PHOSPHATE | HIKMA | ANDA 075183 | — | Mar 26, 2003 | |
| PREDNISOLONE SODIUM PHOSPHATE | PHARM ASSOC | ANDA 076123 | — | Dec 23, 2002 | |
| PREDNISOLONE SODIUM PHOSPHATE | WE PHARMS | ANDA 075181 | — | Dec 23, 2002 | |
| PREDNISOLONE SODIUM PHOSPHATE | BAUSCH | ANDA 075250 | — | Jul 12, 2002 | |
| PREDNISOLONE SODIUM PHOSPHATE | PHARMOBEDIENT CNSLTG | ANDA 075099 | — | Jun 28, 2002 | |
| ORAPRED | CONCORDIA PHARMS INC | ANDA 075117 | — | Dec 14, 2000 | |
| PREDNISOLONE SODIUM PHOSPHATE | BAUSCH AND LOMB | ANDA 040065 | — | Jul 29, 1994 | |
| PREDNISOLONE SODIUM PHOSPHATE | BAUSCH AND LOMB INC | ANDA 040070 | — | Jul 29, 1994 | |
| PREDNISOLONE SODIUM PHOSPHATE | ALCON PHARMS LTD | ANDA 081043 | — | Oct 24, 1991 | |
| PREDNISOLONE SODIUM PHOSPHATE | ALCON PHARMS LTD | ANDA 081044 | — | Oct 24, 1991 | |
| PREDAIR | PHARMAFAIR | ANDA 088415 | — | Feb 29, 1984 | |
| PREDAIR FORTE | PHARMAFAIR | ANDA 088165 | — | Mar 28, 1983 | |
| PREDNISOLONE SODIUM PHOSPHATE | WATSON LABS | ANDA 080517 | — | Approved Prior to Jan 1, 1982 | |
| INFLAMASE FORTERLD×2 | NOVARTIS | ANDA 080751 | — | Approved Prior to Jan 1, 1982 | |
| METRETON | SCHERING | ANDA 083834 | — | Approved Prior to Jan 1, 1982 | |
| PREDNISOLONE SODIUM PHOSPHATE×2 | EPIC PHARMA LLC | ANDA 083358 | — | Approved Prior to Jan 1, 1982 | |
| PREDNISOLONE SODIUM PHOSPHATE | SOLA BARNES HIND | ANDA 084171 | — | Approved Prior to Jan 1, 1982 | |
| PREDNISOLONE SODIUM PHOSPHATE | SOLA BARNES HIND | ANDA 084168 | — | Approved Prior to Jan 1, 1982 | |
| PREDNISOLONE SODIUM PHOSPHATE | SOLA BARNES HIND | ANDA 084169 | — | Approved Prior to Jan 1, 1982 | |
| PREDNISOLONE SODIUM PHOSPHATE | SOLA BARNES HIND | ANDA 084172 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Prednisolone sodium phosphate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

